HBV relapse after discontinuation of Tenofovir alafenamide or Entecavir in non-cirrhotic HBeAg-negative patients. Huang YJ, Lee SW, Tung CF, Liao SC, et al. Dig Dis 2025 Feb 21:1-15. doi: 10.1159/000544870.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Huang YJ, Lee SW, Tung CF, Liao SC, et al. HBV relapse after discontinuation of Tenofovir alafenamide or Entecavir in non-cirrhotic HBeAg-negative patients. Dig Dis 2025 Feb 21:1-15. doi: 10.1159/000544870.
PMID: 39987903